MedTrace Logo

Time at VO2max During High-Intensity Interval Training

NCT06636916 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2024-10-15

No results posted yet for this study

Summary

The project titled "Time at VO2max During High-Intensity Interval Training Manipulating Work and Rest" aims to investigate how different high-intensity interval training (HIIT) protocols influence the time athletes spend at or above 90% of their VO2max. By adjusting the work-to-rest ratios in the HIIT formats, the study seeks to determine which configurations maximize the time spent in this high-intensity zone, contributing to more effective endurance training strategies. The findings could help optimize training protocols for athletes targeting improvements in aerobic capacity and performance.

Conditions

  • High Intensity Interval Exercise (HIIE)

Interventions

PROCEDURE

Short Intervals HIIT

Participants will undergo different high-intensity interval training (HIIT) protocols, which involve repeated bouts of exercise at an intensity above 90% of VO2max, followed by recovery periods. The work and rest durations will vary across the protocols to assess the impact on the total time spent at or above 90% of VO2max.

PROCEDURE

Long intervals HIIT

Participants will undergo different high-intensity interval training (HIIT) protocols, which involve repeated bouts of exercise at an intensity above 90% of VO2max, followed by recovery periods. The work and rest durations will vary across the protocols to assess the impact on the total time spent at or above 90% of VO2max.

Sponsors & Collaborators

  • University of Maia

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-11-30
Primary Completion
2024-12-31
Completion
2025-03-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06636916 on ClinicalTrials.gov